Literature DB >> 21986839

Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib.

G Georgiou, A Efthymiou, I Vardounioti, G Boutsikas, M K Angelopoulou, T P Vassilakopoulos, M-C Kyrtsonis, E Plata, P Tofas, A Bitsani, V Bartzi, I Pessach, M Dimou, P Panayiotidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21986839     DOI： 10.1038/leu.2011.280

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia.

Authors:  Vanya Jaitly; Wei Wang; Shimin Hu
Journal:  Stem Cell Investig       Date:  2015-07-01

2.  Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Authors:  M Schmidt; J Rinke; V Schäfer; S Schnittger; A Kohlmann; E Obstfelder; C Kunert; J Ziermann; N Winkelmann; E Eigendorff; T Haferlach; C Haferlach; A Hochhaus; T Ernst
Journal:  Leukemia       Date:  2014-09-12       Impact factor: 11.528

3.  A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.

Authors:  K Krysiak; M J Christopher; Z L Skidmore; R T Demeter; V Magrini; J Kunisaki; M O'Laughlin; E J Duncavage; C A Miller; B A Ozenberger; M Griffith; L D Wartman; O L Griffith
Journal:  Blood Cancer J       Date:  2016-04-08       Impact factor: 11.037

4.  Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets.

Authors:  Pashtoon M Kasi; Mark R Litzow; Mrinal M Patnaik; Shahrukh K Hashmi; Naseema Gangat
Journal:  Leuk Res Rep       Date:  2016-01-12

5.  Case Report of acute myeloid leukemia with "WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19" developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy.

Authors:  Huan Zhu; Bin Yang; Jia Liu; Wei Wu; Yun Ling
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.